Rectal steroids suppress bone formation in patients with colitis

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 1, 1997, Pages 201-204

  Robinson, R J ^a   Iqbal, S J ^b   Whitaker, R P ^b   Abrams, K ^c   Mayberry, J F ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CORTICOSTEROID; OSTEOCALCIN; PREDNISOLONE 3 SULFOBENZOATE; UNCLASSIFIED DRUG;

ARTICLE; BONE ATROPHY; BONE METABOLISM; CLINICAL ARTICLE; COLITIS; ENTERITIS; ENZYME ACTIVITY; HUMAN; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION;

EID: 0031031782     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.123294000.x     Document Type: Article

References (13)

1. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 410-5.
2. Pigot F, Roux C, Chassade S, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992; 37: 1396-403.
3. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Relat Res 1979; 1: 303-11.
4. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991; 72: 382-6.
5. Jewell DP. Corticosteroids for the management of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1989; 18: 21-33.
6. Pouw EM, Prummel MF, Oosting H, et al. Beclomethasone inhalation decreases serum osteocalcin concentrations. Br Med J 1991; 302: 627-8.
7. Ali NJ, Capewell S, Ward MJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 1991; 46: 160-4.
8. Hodsman AB, Toogood JH, Jennings B, et al. Differential effects of inhaled Budesonide and oral prednisolone on serum osteocalcin. J Clin Endo Metab 1991; 72: 530-40.
9. Powell-Tuck J, Lennard-Jones JE, May CS, Wilson CG, Paterson JW. Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. Br Med J 1976; 1: 193-5.
10. Gundberg CM, Markowitz ME, Miruchi M, Rosen JF. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985; 60: 736-9.
11. Lee D, Taylor M, James VHT, Walker G. Rectally administered prednisolone - evidence for a predominantly local action. Gut 1980; 21: 215-8.
12. Delmas PD. Biochemical Markers of Bone turnover I. Theoretical Considerations and Clinical Use in Osteoporosis. Am J Med 1993; 95(Suppl. 5): 5-15.
13. Meeran K, Hattersley A, Burrin J, et al. Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. Am J Respir Crit Care Med 1995; 151: 333-6.